References
- Smolensky MH, D'Alonzo GE. Medical chronobiology: concepts and applications. Am Rev Respir Dis 1993; 147(6 Pt 2): S2–19
- Sundberg S, Kohvakka A, Gordin A. Rapid reversal of circadian blood pressure rhythm in shift workers. J Hypertens 1988; 6(5): 393–6
- Lemmer B. Chronopharmacology: time, a key in drug treatment. Ann Biol Clin 1994; 52(1): 1–7
- Reinberg AE. Concepts of circadian chronopharmacology. Ann N Y Acad Sci 1991; 618: 102–15
- Dethlefsen U, Repges R. Ein neues Therapieprinzip bei nächtlichem Asthma. Med Klin 1985; 80: 44–7
- Smolensky MH, Scott PH, Harrist RB, et al. Administration-time-dependency of the pharmacokinetic behavior and therapeutic effect of a once-a-day theophylline in asthmatic children. Chronobiol Int 1987; 4(3): 435–47
- Pincus DJ, Humeston TR, Martin RJ. Further studies on the chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy, J Allergy Clin Immunol 1997; 100(6 Pt 1): 771–4
- Beam WR, Weiner DE, Martin RJ. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 1992; 146(6): 1524–30
- Celecoxib product information. Physicians' desk reference. 54th ed. Montvale, NJ: Medical Economics, 2000: 2334–7, 2901–4
- Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol 1995; 95(5 Pt 2): 1084–96
- Reinberg A, Gervais P, Ugolini C, et al. A multicentric chronotherapeutic study of mequitazine in allergic rhinitis. In: Reinberg A, Smolensky M, Labrecque G, eds. Biological rhythms and medications. Annual review of chronopharmacology. Vol 3. Elmsford, NY: Pergamon Press, 1986: 441–4
- Khasawneh SM, Affarah HB. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing. Am J Gastroenterol 1992; 87(9): 1180–2
- Jones PJ, Schoeller DA. Evidence for diurnal periodicity in human cholesterol synthesis. J Lipid Res 1990; 31: 667–73
- Saito Y, Yoshida S, Nakaya N, et al. Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects: a double-blind comparative study. Arterioscl Thromb 1991; 11(4): 816–26
- Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333(20): 1301–7
- Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999; 341(7): 498–511
- Rivard GE, Infante-Rivard C, Dresse MF, et al. Circadian time-dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-term follow-up study of survival. Chronobiol Int 1993; 10(3): 201–4
- Schmiegelow K, Glomstein A, Kristinsson J, et al, for the Nordic Society for Pediatric Hematology and Oncology (NOPHO). Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1997; 19(2): 102–9
- Koren G, Langevin AM, Olivieri N, et al. Diurnal variation in the pharmacokinetics and myelotoxicity of mercaptopurine in children with acute lymphocytic leukemia. Am J Dis Child 1990; 144(10): 1135–7
- Lévi F, Zidani R, Misset JL, for the International Organization for Cancer Chronotherapy. Randomised multicentre trial of chronotherapy with oxaliplatin, flu- orouracil, and folinic acid in metastatic colorectal cancer. Lancet 1997; 350(9079): 681–6
- Cohen MC, Rohtla KM, Lavery CE, et al. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997; 79(11): 1512–6
- Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 1998; 29(5): 992–6
- Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood pressure. Lancet 1978; 1: 795–7
- White WB, Black HR, Weber MA, et al. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate- blood pressure product. Am J Cardiol 1998; 81: 421–31
- Frishman WH, Glasser S, Stone P, et al. Comparison of controlled-onset extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. Am J Cardiol 1999; 83: 507–14
- Black HR, Elliott WJ, Neaton JD, et al. Rationale and design for the Controlled ON set Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial. Control Clin Trials 1998; 19(4): 370–90